styramate
{{short description|Chemical compound}}
{{Drugbox
| verifiedrevid = 447817592
| IUPAC_name = (2-hydroxy-2-phenylethyl) carbamate
| image = Styramate.svg
| tradename =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 94-35-9
| ATC_prefix = M03
| ATC_suffix = BA04
| PubChem = 7186
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = CBK7Y28SP3
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07274
| ChemSpiderID = 6918
| C=9 | H=11 | N=1 | O=3
| smiles = C1=CC=CC=C1C(COC(=O)N)O
| StdInChI = 1S/C9H11NO3/c10-9(12)13-6-8(11)7-4-2-1-3-5-7/h1-5,8,11H,6H2,(H2,10,12)
| StdInChIKey = OCSOHUROTFFTFO-UHFFFAOYSA-N
}}
Styramate (brand name Sinaxar) is a muscle relaxant and anticonvulsant drug. At therapeutic doses, it does not produce significant sedative effects.
See also
Further reading
{{refbegin}}
- {{cite journal | vauthors = De Salva S, Evans R | title = Anticonvulsive character of styramate and other depressant drugs | journal = Toxicology and Applied Pharmacology | volume = 2 | issue = 4 | pages = 397–402 | date = July 1960 | pmid = 13815010 | doi = 10.1016/0041-008X(60)90006-5 }}
- {{cite journal | vauthors = Billow BW, Martorella FJ, Paley SS | title = Clinical experiences with styramate, a nonsedative skeletal muscle relaxant | journal = International Record of Medicine | volume = 173 | pages = 35–8 | date = January 1960 | pmid = 13800722 }}
{{refend}}
{{Muscle relaxants}}
{{GABAAR PAMs}}
Category:GABAA receptor positive allosteric modulators
{{musculoskeletal-drug-stub}}